Exit 156 Capital
Growth equityCollegeville · Growth–Late Stage · 3 people tracked
Find your way into Exit 156 Capital
Investment thesis
Exit 156 Capital seeks non-controlling investments in companies scaling innovative business models in compelling markets. Its strategy centers on pairing distinctive, growth-oriented opportunities with strong financial expertise and a network of operating partners. The firm specializes in small and middle-market businesses that hold defensible market positions within healthcare services, devices, and technology. It follows a disciplined, people-focused investment philosophy, prioritizing strong and proven management teams where the firm can add value. A streamlined structure and flat operating model let the firm evaluate and close transactions quickly, forging aligned partnerships with managers focused on growth and success.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website
What they invest in
from 5 of 6 portfolio companiesHealthtech ×5Digital Health ×3Medical Devices ×2SaaS ×2Biotech ×1Deep Tech ×1Future of Work ×1HR Tech ×1
HQs:United States×4
Investments · 6 tracked
founders shown can be your intro pathBy year:2026 · 12023 · 12 dated
Blue Wolf Body Sculpting is a cosmetic body-contouring provider offering liposuction, awake liposuction, belly fat removal, and body contouring services to individuals seeking fat reduction.
HealthtechWellness & FitnessMidwest, US
Humla Health operates a staffing platform that connects W-2 nurses directly with health care facilities for per diem shifts and long-term assignments, letting nurses set their own schedules and minimum pay rates.
Future of WorkHealthtechHR TechMarketplacesSaaS
NightWare is an FDA-cleared prescription digital therapeutic system designed to interrupt nightmares as they occur, improving sleep quality for patients with Nightmare Disorder, including those with PTSD.
Digital HealthHealthtechMedical DevicesMental HealthHopkins, US
Matthew Tucker(Executive Officer, Director)inGrady Hannah(Director)Michael Nathan(Executive Officer, Director)
BoardMichael Ott(Director)Gerald Mattys(Director)
UrgentIQ provides an AI-native electronic medical record and practice management system designed specifically for urgent care centers, handling patient intake, clinical documentation, coding, and billing.
Digital HealthHealthtechSaaSNew York, US
Nathaniel Gibbs(Executive Officer, Director, Promoter)inEric Slater(Executive Officer, Director, Promoter)
Vail Scientific develops VSNO, a non-invasive, point-of-care diagnostic tool for rapid screening of patients suspected of having sepsis to aid in triage.
BiotechDeep TechDigital HealthHealthtechMedical DevicesMinneapolis, US
Tom Burke(CEO)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CLO-CLO Foods
Portfolio news
latest coverage across their companiesNightWare · sleepreviewmag.com · Apr 15, 2026
Frequently asked questions
- How many investments has Exit 156 Capital made?
- Exit 156 Capital has 6 tracked investments, including 1 dated in the last 24 months.
- What stage does Exit 156 Capital invest at?
- Exit 156 Capital invests at the Growth, Late Stage stages.
- What sectors does Exit 156 Capital focus on?
- Exit 156 Capital focuses on Digital Health, Healthtech, Medical Devices.
- Where is Exit 156 Capital located?
- Exit 156 Capital is headquartered in Collegeville, US.
- Does Exit 156 Capital lead rounds?
- Exit 156 Capital typically participates in rounds rather than leading them.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Flare Capital Partners is a healthcare technology-focused venture firm that partners with founders building companies to improve outcomes, lower costs, and reshape healthcare delivery.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.